Puma Biotechnology | PBYI - Action





Action Changement Date
Agios Pharmaceuticals USD 35.75M 665K 2026-06
Alnylam Pharmaceuticals USD 97.11M 103.04M 2026-06
Amgen USD 6.22B 34M 2026-06
Biogen USD 2.38B 435.3M 2026-06
BioMarin Pharmaceutical USD 1.78B 509.3M 2026-06
Daiichi Sankyo JPY 692.38B 83.83B 2026-03
Exelixis USD 28.73M 2.12M 2026-06
Gilead Sciences USD 1.91B 140M 2026-03
Glaxosmithkline GBP 6.16B 39M 2026-03
Incyte USD 112.54M 3.08M 2026-06
MacroGenics USD 9.5M 1.59M 2026-03
Moderna USD 280M 134M 2026-06
Novartis USD 6.22B 66M 2026-06
Pfizer USD 9.94B 722M 2026-06
PTC Therapeutics USD 91.35M 15.79M 2026-06
Puma Biotechnology USD 9.48M 885K 2025-09
Regeneron Pharmaceuticals USD 3.08B 19.3M 2026-06
Roche Holding CHF 7.6B 9M 2025-06
Sarepta Therapeutics USD 904.27M 96.84M 2026-06
Takeda JPY 1.45T 50.64B 2026-06
TG Therapeutics USD 147.97M 18.94M 2026-06
Ultragenyx Pharmaceutical USD 59M 4M 2026-06
Vanda Pharmaceuticals USD 1.85M 190K 2025-12
Vertex Pharmaceuticals USD 1.77B 1.6M 2026-06